StockData

Celestica vs Plexus

CLS and PLXS side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CLS and PLXS compare

Celestica grew revenue faster over the last twelve months (47.3% versus 1.8% for Plexus).

Celestica keeps more of each dollar of sales as profit, with a net margin of 7.2% compared with 4.6% at Plexus.

Celestica scores higher on the StockData Score (16 against 13 for Plexus), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCLSPLXS
Size and price
Market cap–$5.5B
Share price$265.53$207.96
Change, 1 year−21.4%49.1%
Change, 5 years2312%120%
Beta (5Y)1.870.90
Employees–20K
StockData Score
Total score16 (better)13
Valuation score02 (better)
Growth score6 (better)3
Performance score6 (better)5
Health score4 (better)3
Dividend score00
Valuation
P/E–30.7×
P/S–1.4×
P/B–3.6×
EV/EBITDA–17.0×
P/FCF–89.6×
PEG–3.48
FCF yield–1.1%
Fair value–$182.17
Margin of safety–−14.2%
Growth
Revenue growth (TTM)47.3% (better)1.8%
Revenue growth, 5Y average16.6% (better)2.9%
Net income growth (TTM)107% (better)14.0%
EPS growth (TTM)109% (better)15.5%
EPS growth, 5Y average72.4% (better)9.8%
Profitability
Gross margin12.0% (better)11.4%
Operating margin8.8% (better)5.7%
Net margin7.2% (better)4.6%
FCF margin3.3% (better)1.5%
Return on equity52.7% (better)12.6%
Return on invested capital46.0% (better)16.6%
Financial health
Debt / equity0.33–
Net debt / EBITDA0.18–
Interest coverage21.9× (better)18.0×
Current ratio1.231.49 (better)
Altman Z-score–4.03
Piotroski F-score79 (better)
Dividends and buybacks
Buyback yield–1.5%
Shareholder yield–1.5%
Ownership
Held by institutions69.0%101%
Held by insiders0.81%1.4%
Insider net buying, 12 months−$254M−$23.7M (better)
Superinvestors holding1–
Short interest, % of float3.9%3.5%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.